Advertisement

Genentech Inc.: The South San Francisco-based biotechnology...

Share
From Times Staff and Wire Reports

Genentech Inc.: The South San Francisco-based biotechnology company said second-quarter profits fell 45% to $5.3 million. Revenue rose 15% to $112.5 million. The main reason for the earnings decline was $7.2 million in expenses related to a proposed merger with Roche Holdings Inc., the company said.

Advertisement